{"version":"1.0","type":"link","title":"Impact of adding immune checkpoint inhibitors to standard therapies in non-small cell lung cancer: A systematic review of efficacy outcomes.","author_name":"Correia AP 외","author_url":"https://prs-insight.online/author/Correia%20AP","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/85034","thumbnail_width":1200,"thumbnail_height":630}